Dr. Sally York is a medical oncologist and research scientist whose primary clinical focus is on treating patients with lung cancer, thymic cancers, mesothelioma, and other thoracic malignancies. She practices at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Institute, where she is an Assistant Professor of Medicine. She is also the Associate Director for Clinical
Dr. Joel Neal is a thoracic oncologist who treats patients with lung cancer, pleural mesothelioma, and other thoracic malignancies at the Stanford Cancer Institute in Palo Alto, California. He also designs clinical trials, which focus on overcoming acquired resistance to targeted therapies, understanding and improving the efficacy of immunotherapy, and applying circulating tumor DNA technology.
Dr. Horn is a medical oncologist and researcher, and Senior Vice President for Late Development Oncology at AstraZeneca. Speaking of her work, she says, “Recent research has helped us better understand lung cancer biology and our approach to targeted therapy, immunotherapy, and ADCs, individualizing therapy for more patients and addressing mechanisms of resistance. I’m excited
Dr. Fadi S. Braiteh is a medical oncologist at Comprehensive Cancer Centers of Nevada. Board-certified in Medical Oncology, Internal Medicine, and Palliative Medicine, he specializes in the treatment of gastrointestinal and digestive system cancers, breast cancer, and thoracic malignancies, including lung cancer and pleural mesothelioma. Education and Career Dr. Braiteh earned his medical degree from
Dr. Anita Lyn Sabichi is a medical oncologist at the Baylor College of Medicine, the Dan L. Duncan Comprehensive Cancer Center, and the Michael E. DeBakey VA Medical Center in Houston, Texas. She works to carry the results of her translational biology and molecular medicine research into patient treatment in order to create the most
Dr. Scott Antonia is a recognized leader in the research and clinical application of immunotherapy for the treatment of pleural mesothelioma and lung cancer. He practices at the Duke Cancer Institute (DCI), is a member of the Duke Human Vaccine Institute, and is the Director of the DCI Center for Cancer Immunotherapy. Dr. Antonia is
Dr. Ciunci is a medical oncologist at the Hospital at the Abramson Cancer Center in Philadelphia, Pennsylvania. Her clinical expertise is in thoracic malignancies, including pleural mesothelioma and lung cancer. Dr. Ciunci is part of the multidisciplinary team for the Penn Lung Cancer Program, the Penn Mesothelioma Program, and the Penn Pleural Disease Program. She
Dr. Thompson is a medical oncologist who treats patients diagnosed with lung cancer, pleural mesothelioma, thymoma, and thymic tumors. He practices at the Froedtert Hospital Cancer Center, affiliated with the Medical College of Wisconsin in Milwaukee, Wisconsin. Education and Career Dr. Thompson earned his medical degree at the Medical College of Wisconsin and completed his
Dr. Alberto A. Chiappori is a medical and thoracic oncologist at the Moffitt Cancer Center and Research Institute in Tampa, Florida. He is a Senior Member of Oncology and Medicine for the Thoracic Oncology Program. He specializes in treating patients diagnosed with lung cancer and pleural mesothelioma, as well as pleural neoplasms. Education and Career
Dr. Michael Shafique is a thoracic oncologist at the Moffitt Cancer Center in Tampa, Florida. He specializes in treating patients with lung cancer, pleural mesothelioma, neuroendocrine tumors, Pancoast tumors, and thymomas, as well as gynecologic malignancies. Education and Career Dr. Shafique earned his undergraduate degree in Finance at the Wharton School of the University of